Göttingen, Germany | Yauco, Puerto Rico – June 18, 2019 Investment of more than 100 million U.S. dollars Area designed for future growth After investing more than 100 million U.S. dollars, Sartorius, a leading international partner of biopharmaceutical research and the industry, started up its expanded manufacturing operations in Yauco, Puerto Rico. The U.S. market is... Read more
New facility in Frederick, Colorado, to produce high-quality molecules with the potential to treat cancer and other diseases SANTA CLARA, Calif., June 18, 2019 Agilent Technologies Inc. (NYSE: A) today announced the opening of a production facility in Colorado that more than doubles its capacity to develop and manufacture “oligos,” which are short DNA and... Read more
Development of customized drug discovery assays and image analyses upon request June 13, 2019 Nikon Corporation (Toshikazu Umatate, President, Tokyo) and its subsidiary Nikon Instruments Inc. (Toshiaki Nagano, President, NY, USA) have established the Nikon BioImaging Lab in Boston, USA to provide contract imaging and assay services for pharmaceutical companies and venture companies involved in... Read more
Medidata Solutions’ market-leading clinical cloud solutions are used by 1,300 customers worldwide to develop their therapeutic innovations and clinical operations performance •Scientific modeling, simulation and digital assets of worldwide trials knowledge and know-how combine to accelerate developments in personalized health, for the benefit of the patient •Life Sciences industry will also benefit from the platform effect spanning... Read more
Agilent Companion Diagnostic Gains Expanded FDA Approval in Head and Neck Squamous Cell Carcinoma (HNSCC) PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify HNSCC patients for treatment with KEYTRUDA® (pembrolizumab) SANTA CLARA, Calif., June 11, 2019 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration... Read more
Basel, 04 June 2019 Pivotal phase III CLL14 results for Venclexta/Venclyxto in combination with Gazyva/Gazyvaro for chronic lymphocytic leukaemia presented at ASCO 2019 and published in the New England Journal of Medicine Venclexta/Venclyxto plus Gazyva/Gazyvaro showed improvements across multiple efficacy measures compared to Gazyva/Gazyvaro plus chlorambucil, including progression-free survival and deep remissions as determined by... Read more
Agilent Survey of Pharma Lab Leaders Uncovers Challenges in Workflow and Laboratory Efficiencies SANTA CLARA, Calif., June 4, 2019 Agilent Technologies Inc. (NYSE: A) announced today the results of its first Pharma Lab Leaders Survey looking to gather insights from pharmaceutical, biopharmaceutical, and contract research laboratories in seven countries around the world. Respondents included 650... Read more
March 28, 2019 Collaboration will help drug manufacturers improve efficiencies, get to market faster and deliver personalized medicines with innovative solutions Joint work is pivotal step in transforming biopharmaceutical manufacturing to meet the needs of the biopharma 4.0 era Chicago, IL and Milwaukee, WI, US – March 28, 2019 – GE Healthcare and Rockwell Automation are combining their... Read more
Demonstrates MilliporeSigma’s commitment to the UK Only MilliporeSigma facility to produce both liquid and powder cell culture media Irvine, Scotland, May 27, 2019 — MilliporeSigma, a leading science and technology company, today announced the completion of a £2.7 million expansion to its Irvine biopharmaceutical production facility. The site is MilliporeSigma’s only location where both liquid and... Read more
Basel, 16 May 2019 Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic lymphocytic leukaemia Fixed 12-month treatment with Venclexta plus Gazyva significantly reduced risk of disease progression or death by 67% compared to a current standard-of-care Approval for expanded use of Venclexta offers more adults with chronic lymphocytic leukaemia... Read more